M. Back et al., Prostacyclin modulation of contractions of the human pulmonary artery by cysteinyl-leukotrienes, EUR J PHARM, 401(3), 2000, pp. 389-395
The contractile response to cysteinyl-leukotrienes was studied in isolated
human pulmonary arterial rings. Concentration-response curves for leukotrie
ne C-4 were significantly potentiated by the cyclooxygenase inhibitor indom
ethacin (1.7 mu M) and after endothelial denudation. Measurements of 6-keto
prostaglandin F-1 alpha showed that cysteinyl-leukotrienes stimulated the
release of prostacyclin. A single concentration (1 mu M) of either leukotri
ene C-4 or leukotriene D-4 resulted in both contraction and relaxation. Ind
omethacin abolished the relaxant phase and enhanced the amplitude of the co
ntraction, supporting that cysteinyl-leukotriene-induced contractions of th
e human pulmonary artery may be functionally antagonised by the release of
prostacyclin. The contractions induced by leukotriene C-4 were resistant to
the two cysteinyl-leukotriene receptor antagonists MK 571 ((3-(-2(7-chloro
-2-quinolinyl)ethenyl)phenyl)((3-(dimethyl-amino-3-oxopropyl)thio)methyl)th
io propanoic acid, 1 mu M) and BAY u9773 (6(R)-(4'-carboxyphenylthio)-5(S)-
hydroxy-7(E), 11(Z)14(Z)-eicosatetrenoic acid, 3 mu M), both in the absence
and presence of indomethacin. These findings suggest a functional cysteiny
l-leukotriene receptor in the human pulmonary artery with antagonist proper
ties not previously described in human tissue. (C) 2000 Elsevier science B.
V. All rights reserved.